Location: Newton, MA
Search
Close this search box.

Lumicell Announces Initial Data Demonstrating LUMISIGHT™’s Ability to Detect Tumors Metastasized to Multiple Organs in the Peritoneum

Promising feasibility study results for imaging technology that identified malignant peritoneal tumor metastasis during surgery NEWTON, Mass.–(BUSINESS WIRE)–Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced promising initial data from its ongoing feasibility study for lead candidate LUMISIGHT™ to detect peritoneal malignancies during surgical debulking. The ongoing study is utilizin...
Read More

Lumicell Co-Founder Moungi Bawendi Awarded Nobel Prize in Chemistry

Bawendi’s expertise in optics, fluorescent molecules and tissue imaging were instrumental in development of Lumicell Direct Visualization System, which is currently under FDA review NEWTON, Mass., October 5, 2023—Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced company co-founder Moungi G. Bawendi, PhD, is one of three recipients of the Nobel Prize in Chemistry 2023 for the discovery and synthesis of q...
Read More

Lumicell Appoints Brent Palmisano Chief Commercial Officer, Builds Commercial Team

Lumicell, Inc. today announced it is building a commercial team to prepare for market launch of the Lumicell Direct Visualization System (DVS) which includes its novel optical imaging agent LUMISIGHT, upon FDA approval....
Read More

Howard Hechler Joins Lumicell as Senior Vice President of Strategy & Business Development

Hechler brings more than 15 years of focused life-sciences experience in M&A, strategy, andoperations Newton, Mass., Sept. 16, 2020 – Lumicell, Inc., a leader in image-guided cancer surgery, today announced the addition of Howard Hechler as Senior Vice President of Strategy & Business Development. In this new role, Mr. Hechler will leverage his depth of transactional and operational experience across a range of life sciences technologies to optimize and execute Lumicell’s c...
Read More

Lumicell Headquarters Expands Into New Boston-Area Office Space

New location offers more space for expansion and designed to inspire innovation of Lumicell technology through further employee collaboration Newton, Mass., Feb. 22, 2019— Lumicell, Inc., an innovation leader in molecular imaging within healthcare focused in cancer, perfusion, wound care and infection, has expanded into a new headquarters location in Newton, Mass., just outside of Boston. The new office space at One Newton Place, 275 Washington St., is over 20K sq. ft. in size and has been com...
Read More

Lumicell Expands Development Strategy and Pipeline Across Five Solid Tumor Cancers Supported by $28.7 Million Series C Financing

Proceeds to Fund Pivotal Trial in Breast Cancer Leverages Broad Potential of LUM System with Drug, Device and Software for Real-time Detection of Tumor Tissue in Patients During Surgery Wellesley, Mass., Dec. 7, 2017— Lumicell, Inc., a technology leader in the field of image-guided cancer surgery, today provided an update on the company’s development strategy for its LUM system pipeline including plans to initiate its pivotal trial in breast cancer as well as expansion of its clini...
Read More

Lumicell to Participate in Upcoming Conferences

Wellesley, Mass., September 5, 2017— Lumicell, Inc., a technology leader in the field of image-guided cancer surgery, announced today that management will participate in two upcoming September meetings, including:  “We are delighted to represent Lumicell at these important industry meetings and look forward to providing further updates on our progress with the LUM System in the coming weeks,” said Kelly Londy, Chief Executive Officer of Lumicell. About Lumicell, Inc. Lumicell is a tec...
Read More

Lumicell Appoints Kelly Londy as Chief Executive Officer, Announces Additional Financing

Wellesley, Mass., July 12, 2017 – The Board of Directors of Lumicell, Inc., a leader in the field of image-guided cancer surgery, announced today the appointment of Kelly Londy as Chief Executive Officer and member of the Board of Directors. W. David Lee, Founder of Lumicell, has moved into the role of President and Chief Scientific Officer. Dr. Andrey Zarur, Chairman of the Board of Lumicell, said “We are extremely excited to welcome Kelly to Lumicell. Kelly was chosen as CEO for her p...
Read More

Lumicell Appoints Felix Geissler, M.D., Ph.D. as Chief Medical Officer

Wellesley, Mass., June 28, 2017 – Lumicell, a leader in the field of image-guided cancer surgery, today announced the appointment of Felix Geissler, M.D., Ph.D. as Chief Medical Officer. As a central member of Lumicell’s senior executive team, he will drive the clinical direction of the company and will work closely with the R&D and marketing teams to develop the overall business strategy. Dr. Geissler previously held various roles within Sanofi Genzyme. Most recently, he was t...
Read More

Lumicell Awarded SBIR Phase IIB Grant from National Science Foundation

Grant will support development of novel image-guided laser ablation system in collaboration with Massachusetts General Hospital, Brigham and Women’s Hospital and Duke University Medical Center Wellesley, Mass., May 14, 2014 – Lumicell, a leader in the field of image-guided cancer surgery, has received a Phase IIB Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The grant will support the company’s expansion into brain and ovarian cancer indic...
Read More